Altre lingue Elanco Animal Health Incorporated

Azioni

ELAN

US28414H1032

Prodotti farmaceutici

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 05/06/2026			Variaz. 5gg	Var. 1 gen.
23,63 ^USD	-4,37%		-0,92%	+4,42%

04/06	Elanco Animal Health annuncia un portafoglio di opzioni terapeutiche e consulenza specialistica dopo il primo caso confermato di mosca carnivora del Nuovo Mondo negli Stati Uniti	CI
02/06	Elanco Animal Health Incorporated Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 03:20 PM

Altre lingue

04/06	Elanco Animal Health Announces Portfolio of Treatment Options and Expert Guidance Following First Confirmed Case of New World Screwworm in United States
04/06	Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
03/06	New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience
18/05	Elanco Animal Health Launches Canine Dermatitis Drug Befrena
18/05	Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
18/05	Elanco Animal Health Incorporated Launches Befrena, New Anti-IL-31 Monoclonal Antibody
14/05	Elanco to Participate in Upcoming Investor Conferences
06/05	Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026
06/05	Elanco Animal Health Incorporated : Investor Overview
06/05	Elanco Animal Health Q1 Adjusted Earnings, Revenue Rises; Lifts 2026 Outlook
06/05	(ELAN) Elanco Animal Health Expects 2026 Revenue Range $5.01B to $5.09B, vs. FactSet Est of $5.00B
06/05	(ELAN) Elanco Animal Health Incorporated Expects Q2 Revenue Range $1.30B - $1.33B
06/05	(ELAN) Elanco Animal Health Incorporated Expects Q2 Adjusted EPS Range $0.25 - $0.28
06/05	(ELAN) Elanco Animal Health Expects 2026 Adjusted EPS Range $1.03 to $1.09, vs. FactSet Est of $1.03
06/05	Earnings Flash (ELAN) Elanco Animal Health Incorporated Reports Q1 Revenue $1.37B, vs. FactSet Est of $1.28B
06/05	Earnings Flash (ELAN) Elanco Animal Health Incorporated Posts Q1 Adjusted EPS $0.40 per Share, vs. FactSet Est of $0.35
06/05	Elanco Animal Health Reports First Quarter 2026 Results
06/05	Elanco Animal Health Incorporated Provides Earnings Guidance for the Second Quarter of 2026
06/05	Elanco Animal Health Incorporated Raises Earnings Guidance for the Full Year 2026
30/04	Elanco Animal Health Incorporated acquired AHV International B.V. on April 30, 2026.
28/04	/C O R R E C T I O N -- Elanco Animal Health/
28/04	Elanco Animal Health Incorporated Receives Emergency Authorization for Negasunt Powder and Tanidil Against New World Screwworm in Livestock
27/04	Elanco Animal Health Gets FDA, EPA Emergency Authorizations for Screwworm Treatments
27/04	National Veterinary Associates Appoints Todd S. Young as Chief Financial Officer
16/04	Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement